What's happened
Spire Healthcare has received a non-binding 250p-a-share cash proposal from Toscafund Asset Management, sending its stock higher as the board considers a potential offer worth about £1.01 billion. The talks follow a broader strategic review and mark the second major private equity approach to UK private hospitals this year.
What's behind the headline?
Context and implications
- Toscafund, led by Martin Hughes, has previously led takeovers and is pressing to secure a deal at 250p per share.
- Spire has a diversified mix of private and NHS-backed work, with over 1.36 million patients treated in 2025 and NHS-related revenue making up a meaningful portion.
- Market reaction shows investor optimism, as the shares jumped toward 221p, giving a market cap near £892 million prior to a potential firm offer.
- Analysts view this as a continuation of consolidation in UK private healthcare, with the board signaling willingness to recommend a firm offer should terms be improved and due diligence be satisfied.
- If the deal proceeds, it could reshape ownership in a sector sensitive to public/private balance and political pressure over privatisation.
Forecast
- A firm bid by 11 June would be pivotal; if not, the process could pause or continue exploring other suitors.
- The outcome will hinge on regulatory review and strategic fit with Spire’s NHS-facing operations.
How we got here
Spire Healthcare operates 38 private hospitals and 60 clinics across the UK. The company has disclosed a strategic review has been ongoing since last year, with talks previously engaging Bridgepoint and Triton. A 250p offer would value the group at roughly £1.01 billion, and comes amid ongoing debate about private sector involvement in the NHS.
Our analysis
The Guardian (Julia Kollewe) reports that Spire Healthcare has received a non-binding cash proposal at 250p per share from Toscafund Asset Management, valuing the group around £1.01 billion and prompting a sharp share rise. The Independent (Holly Williams) confirms early-stage discussions and market optimism around the same bid, noting Toscafund’s 18% stake and the board’s willingness to pursue a firm offer if due diligence is satisfactory. Both outlets reference previous talks with Bridgepoint and Triton and outline the broader question of private equity involvement in UK private healthcare.
Go deeper
- Will Spire accept a firm offer if due diligence confirms value?
- How would a takeover affect NHS-facing services at Spire sites?
- What are the next milestones before a potential firm bid by 11 June?
More on these topics
-
Intertek - Company
Intertek Group plc is a British multinational assurance, inspection, product testing and certification company headquartered in London, England. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
-
Toscafund Asset Management - Corporation
Toscafund Asset Management is a London based investment firm which is a major investor in Circle Health Ltd. It has assets of £4 billion.
-
EQT Partners - Swedish private equity firm
EQT AB is a Swedish global investment organization founded in 1994. Its funds invest in private equity, infrastructure, real estate, growth equity, and venture capital in Europe, North America, and Asia Pacific. As of 2022, EQT's assets under management..
-
Spire Healthcare - Healthcare company
Spire Healthcare plc is the second largest provider of private healthcare in the United Kingdom. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.